Type of Intervention: Specific Action
Sectors Involved: Health, Research and Development
Intervention Categories: Biological measures; Planning and strategy; Creation of or release of plans
Level of Jurisdiction: National
Lead People/Agency: Ministry of Health and Ministry of Science and innovation
Overview: Spain signs up to centralised purchasing of Astrazeneca vaccine from European Commission
The European Commission (EC) has been negotiating in recent weeks for the centralised purchasing of the Astrazeneca vaccine, developed by researchers from Oxford University. This vaccine is one of the most advanced alternatives, and clinical trials are already underway to guarantee its safety and efficacy.
Spain, together with other Member States, has signed up to purchasing this vaccine. The distribution will be carried out fairly among countries, according to population size. Aside from this initial agreement, the EC’s negotiating committee is in talks with the different companies that are developing alternative vaccines to satisfy the vaccination needs of the European Union and of third countries.
This vaccine is one of the most advanced alternatives, and clinical trials are already underway to guarantee its safety and efficacy. Spain, together with other Member States, has signed up to purchase this vaccine. The distribution will be carried out fairly among countries, according to population size.
Full details here: https://www.lamoncloa.gob.es/lang/en/gobierno/news/Paginas/2020/20200825vaccine.aspx
Type of Justification: Advice of INTERNAL government advisory committee or group
Source of Evidence or Justification: World Health Organisation, National – academic, National – government, International – academic, International – government, European Union